✦ LIBER ✦

CC 5013 shows activity in relapsed or refractory multiple myeloma

Book ID: 120861953
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213660-00020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CC−4047 shows anti-tumour activity in re

CC−4047 shows anti-tumour activity in relapsed or refractory multiple myeloma

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Thalidomide shows activity in refractory

Thalidomide shows activity in refractory multiple myeloma

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 283 KB

Continuous low-dose dexamethasone in rel

Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma

✍ C. W. Tiplady; G. P. Summerfield 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Pulsed high dose oral prednisolone in re

Pulsed high dose oral prednisolone in relapsed or refractory multiple myeloma

✍ Dr. D. R. Norfolk; J. A. Child 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Seventeen unselected patients with relapsed or refractory multiple myeloma were treated with oral prednisolone 60 mg per m2 for five consecutive days with nine-day treatment-free intervals. Of the fourteen patients who completed at least six courses of treatment there were five good responses (Chron

Tanespimycin with bortezomib: activity i

Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma

✍ Paul G. Richardson; Ashraf Z. Badros; Sundar Jagannath; Stefano Tarantolo; Jeffr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Gemcitabine shows activity in patients w

Gemcitabine shows activity in patients with relapsed or refractory Hodgkin's disease

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB